Dow Jones

38,314.86

-5.50%

Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.

Regístrate

AZTA

Azenta (AZTA)

Azenta Inc

Fecha:

Regulatory News

Text Search:

Ordernar por:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:AZTA

1 2 3 4 5 Próxima >

Fecha	Hora	Fuente	Título	Símbolo	Compañía
24/03/2025	15:05	PR Newswire (US)	Azenta Publishes its 2024 Environmental, Social, & Governance (ESG) Report	NASDAQ:AZTA	Azenta Inc
10/03/2025	16:05	PR Newswire (US)	Azenta to Participate in the Virtual KeyBanc Capital Markets Healthcare Forum	NASDAQ:AZTA	Azenta Inc
13/02/2025	15:10	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:AZTA	Azenta Inc
10/02/2025	16:19	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:AZTA	Azenta Inc
05/02/2025	06:32	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:AZTA	Azenta Inc
05/02/2025	06:00	PR Newswire (US)	Azenta Reports First Quarter Results for Fiscal 2025, Ended December 31, 2024	NASDAQ:AZTA	Azenta Inc
04/02/2025	15:10	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:AZTA	Azenta Inc
30/01/2025	15:05	PR Newswire (US)	Azenta Announces the Election of Dipal Doshi to its Board of Directors	NASDAQ:AZTA	Azenta Inc
27/01/2025	15:05	PR Newswire (US)	Azenta Announces Fiscal 2025 First Quarter Earnings Conference Call and Webcast	NASDAQ:AZTA	Azenta Inc
23/01/2025	15:05	PR Newswire (US)	UK Biocentre Selects the Azenta Life Sciences BioArc Ultra Automated Storage System to Advance Research Excellence	NASDAQ:AZTA	Azenta Inc
17/12/2024	16:30	Edgar (US Regulatory)	Form ARS - Annual Report to Security Holders	NASDAQ:AZTA	Azenta Inc
17/12/2024	16:29	Edgar (US Regulatory)	Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material	NASDAQ:AZTA	Azenta Inc
17/12/2024	16:28	Edgar (US Regulatory)	Form DEF 14A - Other definitive proxy statements	NASDAQ:AZTA	Azenta Inc
06/12/2024	15:32	Edgar (US Regulatory)	Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]	NASDAQ:AZTA	Azenta Inc
19/11/2024	16:56	PR Newswire (US)	Flex Set to Join S&P MidCap 400; Azenta and Concentra Group Holdings to Join S&P SmallCap 600	NASDAQ:AZTA	Azenta Inc
14/11/2024	07:00	PR Newswire (US)	Azenta to Participate in Stephens Annual Investment Conference	NASDAQ:AZTA	Azenta Inc
12/11/2024	15:05	PR Newswire (US)	Azenta Reports Fourth Quarter and Full Year Fiscal 2024 Results; Announces the Plan to Sell B Medical Systems and Appoints Lawrence Y. Lin as CFO	NASDAQ:AZTA	Azenta Inc
04/11/2024	15:05	PR Newswire (US)	Azenta Announces Fiscal 2024 Fourth Quarter and Full Year Earnings Conference Call and Webcast	NASDAQ:AZTA	Azenta Inc
04/11/2024	07:41	Edgar (US Regulatory)	Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]	NASDAQ:AZTA	Azenta Inc
04/11/2024	07:00	PR Newswire (US)	Azenta Announces the Addition of Three New Independent Directors Effective Immediately and New Initiative to Drive Value	NASDAQ:AZTA	Azenta Inc
30/10/2024	15:05	PR Newswire (US)	Azenta Obtains Regulatory Approval for Clinical Long-Read Whole Genome Sequencing Test	NASDAQ:AZTA	Azenta Inc
04/09/2024	07:00	PR Newswire (US)	AZENTA ANNOUNCES APPOINTMENT OF JOHN P. MAROTTA AS CEO	NASDAQ:AZTA	Azenta Inc
12/08/2024	15:05	PR Newswire (US)	GENEWIZ from Azenta Life Sciences Celebrates 25 Years of Advancing Scientific Discoveries at GENEWIZ Week Event	NASDAQ:AZTA	Azenta Inc
06/08/2024	15:05	PR Newswire (US)	Azenta Reports Third Quarter Results for Fiscal 2024, Ended June 30, 2024	NASDAQ:AZTA	Azenta Inc
05/08/2024	15:05	PR Newswire (US)	Azenta to Participate in 9th Annual Needham Virtual MedTech & Diagnostics 1x1 Conference	NASDAQ:AZTA	Azenta Inc
01/08/2024	15:26	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:AZTA	Azenta Inc
24/07/2024	15:05	PR Newswire (US)	Azenta Announces Fiscal 2024 Third Quarter Earnings Conference Call and Webcast	NASDAQ:AZTA	Azenta Inc
22/07/2024	15:05	PR Newswire (US)	FinnGen Selects Azenta to Propel Personalized Medicine for Population Health Study	NASDAQ:AZTA	Azenta Inc
04/06/2024	15:05	PR Newswire (US)	Azenta Announces Collaboration with the Crohn's & Colitis Foundation to Support its Crohn's Disease and Ulcerative Colitis Clinical Research	NASDAQ:AZTA	Azenta Inc
30/05/2024	07:01	Edgar (US Regulatory)	Form SD - Specialized disclosure report	NASDAQ:AZTA	Azenta Inc